MUC1 overexpression appears to be increased with the progression of premalignant lung lesions to invasive carcinoma in patients with NSCLC (significantly for squamous cell carcinoma and with a trend toward significance for adenocarcinoma). The gene discussed is MUC1; the disease is invasive carcinoma.